Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine and naloxone

BUPRENORPHINE AND NALOXONE · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

137 regulatory and trial events tracked for Buprenorphine and naloxone, covering 2013-02-22 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)

See pricing